ATX-006

N/A

Report date: 2024/05/16 17:32:07

Base Information

Drug NameATX-006
Drug Alias NameATX-006ATX006
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-CD6
TargetsT-cell differentiation antigen CD6
Therapy Area/IndicationsAutoimmune DiseasesProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbcon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbcon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A